Skip to main content
CONTEC MEDICAL SYSTEMS CO., LTD. logo

CONTEC MEDICAL SYSTEMS CO., LTD. — Investor Relations & Filings

Ticker · 300869 ISIN · CNE1000047F0 LEI · 6556007SL3V6YKCWVA55 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 789 across all filing types
Latest filing 2022-04-26 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300869

About CONTEC MEDICAL SYSTEMS CO., LTD.

https://www.contecmed.com.cn

CONTEC Medical Systems Co., Ltd. focuses on the research, development, manufacturing, and distribution of medical electronic instruments. The product portfolio encompasses a wide range of diagnostic and monitoring solutions, including pulse oximeters, blood pressure monitors, electrocardiographs, ultrasound equipment, and multi-parameter patient monitors. Additionally, the company provides specialized devices such as fetal monitors, sleep apnea screening systems, and biochemical analyzers. By leveraging integrated research and large-scale production facilities, the organization delivers medical technology designed for clinical, hospital, and home healthcare environments. The company emphasizes technical innovation and adheres to international quality standards to ensure the precision and reliability of its medical hardware and software solutions.

Recent filings

Filing Released Lang Actions
中信建投证券股份有限公司关于康泰医学系统（秦皇岛）股份有限公司使用部分超募资金永久补充流动资金的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from a sponsoring securities company regarding the use of excess raised funds by a listed company to permanently supplement working capital. It references regulatory guidelines and internal approvals but does not contain financial statements or detailed financial results. The document length is about 2600 characters, which is relatively short and more consistent with an announcement or verification opinion rather than a full financial report. It is not an annual or interim report, earnings release, or audit report. It is a regulatory compliance-related verification document concerning the use of raised funds, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories and is a compliance-related disclosure.
2022-04-26 Chinese
中信建投证券股份有限公司关于康泰医学系统（秦皇岛）股份有限公司2021年度内部控制自我评价报告的核查意见
Audit Report / Information Classification · 95% confidence The document is titled as an internal control self-evaluation report for the year 2021 of 康泰医学系统（秦皇岛）股份有限公司, with detailed descriptions of the internal control evaluation scope, methodology, and conclusions. It includes the review and verification opinions from the sponsoring institution (中信建投证券股份有限公司). The content focuses on internal control evaluation, defect identification, and compliance with regulatory requirements. It is not a full annual report or financial statement but a specialized audit-related report on internal controls. The document length is over 6000 characters and contains substantive content, not just an announcement or certification. Therefore, it fits best under the category of Audit Report / Information (AR), which covers standalone audit reports and internal control evaluations. FY 2021
2022-04-26 Chinese
关于募集资金存放与实际使用情况的专项报告及审核报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report on the storage and actual use of raised funds by 康泰医学系统(秦皇岛)股份有限公司, including an audit report by Deloitte. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange regarding the management and use of raised funds. The document includes financial figures, project investment details, changes in project implementation, and compliance statements. It is a specialized report focused on the use of capital raised through public issuance, with an audit opinion on the same. This matches the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document is not a general annual report or audit report alone, but a specific report on fundraising usage and compliance, which fits CAP best. The document length and content confirm it is the report itself, not just an announcement or certification, so it is not RPA or RNS.
2022-04-26 Chinese
拟续聘会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (Deloitte Huayong) as the company's auditor for the year 2022. It details the background of the accounting firm, the qualifications and integrity of the auditors, the audit fees, and the approval process by the board and independent directors. There is no actual audit report or financial statements included, nor is there a detailed audit opinion or results. The document is primarily a formal announcement of the intention to reappoint the auditor, pending shareholder approval. The document length is 2770 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this fits best under the category of Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or audit report itself. However, since it is an announcement of the auditor reappointment and not the audit report itself, it is more appropriate to classify it as Regulatory Filings (RNS) because it does not contain the audit report or financial statements but is a regulatory announcement about audit firm appointment.
2022-04-26 Chinese
2021年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the "2021 Annual Report Summary" of 康泰医学系统（秦皇岛）股份有限公司, indicating it is a summary of the full annual report. It contains detailed financial data for the year 2021, including total assets, net profit, revenue, earnings per share, and shareholder information. It also includes auditor's opinion from Deloitte, which is typical for annual reports. The document is over 7,000 characters, which is substantial and contains actual financial data and analysis, not just an announcement or a certification. Therefore, it is classified as an Annual Report (10-K equivalent). FY 2021
2022-04-26 Chinese
2021年度监事会工作报告
Audit Report / Information Classification · 95% confidence The document is titled as the "2021年度监事会工作报告" which translates to "2021 Supervisory Board Work Report". It details the supervisory board's activities, meetings, and oversight of the company's operations, financials, internal controls, and compliance with laws and regulations during the 2021 fiscal year. It includes opinions on financial reports, internal controls, and fundraising usage, but it is not the financial report itself. The document is a report from the supervisory board summarizing their work and oversight for the year, which aligns with the category of Audit Report / Information (AR) as it includes audit-related oversight and supervisory opinions but is not a full annual report (10-K). The document length is 3266 characters, which is relatively short but contains substantive supervisory content rather than just an announcement or certification. Therefore, the best fit is AR (Audit Report / Information). FY 2021
2022-04-26 Chinese

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.